ORC
BMY icon

O'Rourke & Company’s Bristol-Myers Squibb BMY Stock Holding History

O'Rourke & Company’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$705K Buy
11,628
+342
+3% +$19.9K 0.28% 86
2025
Q4 		$609K Buy
11,286
+2,567
+29% +$123K 0.24% 90
2025
Q3 		$393K Sell
8,719
-102
-1% -$4.76K 0.16% 118
2025
Q2 		$408K Buy
8,821
+77
+0.9% +$3.78K 0.19% 105
2025
Q1 		$533K Buy
8,744
+1,083
+14% +$63.1K 0.26% 81
2024
Q4 		$433K Buy
7,661
+158
+2% +$8.83K 0.21% 96
2024
Q3 		$388K Buy
7,503
+1,702
+29% +$79.8K 0.19% 102
2024
Q2 		$241K Buy
+5,801
New +$260K 0.14% 133
2023
Q4 		– Sell
-6,688
Closed -$388K – 139
2023
Q3 		$388K Sell
6,688
-523
-7% -$32K 0.28% 72
2023
Q2 		$461K Sell
7,211
-1,038
-13% -$69.6K 0.32% 67
2023
Q1 		$572K Sell
8,249
-758
-8% -$53.5K 0.44% 57
2022
Q4 		$648K Buy
9,007
+216
+2% +$16.3K 0.51% 53
2022
Q3 		$625K Sell
8,791
-1,550
-15% -$112K 0.55% 48
2022
Q2 		$796K Sell
10,341
-4,744
-31% -$361K 0.68% 41
2022
Q1 		$1.1M Sell
15,085
-3,200
-18% -$215K 0.76% 34
2021
Q4 		$1.14M Buy
+18,285
New +$1.07M 0.76% 33

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

O'Rourke & Company's BMY Position: Q1 2026 in Review

O'Rourke & Company increased its Bristol-Myers Squibb (BMY) stake by 3% in Q1 2026, buying an estimated $19.9K and bringing the position to 11,628 shares worth $705K. The position accounts for 0.28% of the portfolio, ranked #86.

O'Rourke & Company first reported a position in BMY in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.14M in Q4 2021. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • O'Rourke & Company held 11,628 shares of Bristol-Myers Squibb worth $705K as of Q1 2026.
  • O'Rourke & Company bought 342 Bristol-Myers Squibb shares in Q1 2026, an estimated $19.9K.
  • Bristol-Myers Squibb made up 0.28% of O'Rourke & Company's portfolio in Q1 2026, its #86 holding.
  • O'Rourke & Company first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 16 quarters since.
  • O'Rourke & Company's Bristol-Myers Squibb position peaked at $1.14M in Q4 2021.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on O'Rourke & Company's 13F filing for Q1 2026, filed 14 May 2026.